AV, M., & HT, V. (2018). European Marketing Authorizations Granted Based on a Single Pivotal Clinical Trial: The Rule or the Exception? Clinical pharmacology and therapeutics, 104(1), 169. https://doi.org/10.1002/cpt.900
Chicago Style (17th ed.) CitationAV, Morant, and Vestergaard HT. "European Marketing Authorizations Granted Based on a Single Pivotal Clinical Trial: The Rule or the Exception?" Clinical Pharmacology and Therapeutics 104, no. 1 (2018): 169. https://doi.org/10.1002/cpt.900.
MLA (9th ed.) CitationAV, Morant, and Vestergaard HT. "European Marketing Authorizations Granted Based on a Single Pivotal Clinical Trial: The Rule or the Exception?" Clinical Pharmacology and Therapeutics, vol. 104, no. 1, 2018, p. 169, https://doi.org/10.1002/cpt.900.